Found: 12
Select item for more details and to access through your institution.
Real‐world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA‐SWITCH study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 60, doi. 10.1111/apt.17525
- By:
- Publication type:
- Article
Adherence to endoscopic surveillance for advanced lesions and colorectal cancer in inflammatory bowel disease: an AEG and GETECCU collaborative cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 11, p. 1402, doi. 10.1111/apt.16832
- By:
- Publication type:
- Article
Automedicación y uso de plantas medicinales en estudiantes universitarios de la Amazonía Peruana durante la primera ola por COVID-19.
- Published in:
- Revista del Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo, 2022, v. 15, n. 4, p. 1, doi. 10.35434/rcmhnaaa.2022.154.1545
- By:
- Publication type:
- Article
Initial Management of Intra-abdominal Abscesses and Preventive Strategies for Abscess Recurrence in Penetrating Crohn's Disease: A National, Multicentre Study Based on ENEIDA Registry.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 4, p. 578, doi. 10.1093/ecco-jcc/jjad184
- By:
- Publication type:
- Article
Management and Long-term Outcomes of Crohn's Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCU.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 7, p. 1049, doi. 10.1093/ecco-jcc/jjac016
- By:
- Publication type:
- Article
Hematological Composite Scores in Patients with Inflammatory Bowel Disease.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 23, p. 7248, doi. 10.3390/jcm12237248
- By:
- Publication type:
- Article
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med. 2021, 10 , 2885.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 19, p. 5816, doi. 10.3390/jcm11195816
- By:
- Publication type:
- Article
QRISK3 Performance in the Assessment of Cardiovascular Risk in Patients with Inflammatory Bowel Disease.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 18, p. 4102, doi. 10.3390/jcm10184102
- By:
- Publication type:
- Article
Insulin Resistance Is Not Increased in Inflammatory Bowel Disease Patients but Is Related to Non-Alcoholic Fatty Liver Disease.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 14, p. 3062, doi. 10.3390/jcm10143062
- By:
- Publication type:
- Article
Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 13, p. 2885, doi. 10.3390/jcm10132885
- By:
- Publication type:
- Article
Carotid Plaque Assessment Reclassifies Patients with Inflammatory Bowel Disease into Very-High Cardiovascular Risk.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 8, p. 1671, doi. 10.3390/jcm10081671
- By:
- Publication type:
- Article
Apolipoprotein C3 Is Downregulated in Patients With Inflammatory Bowel Disease.
- Published in:
- Clinical & Translational Gastroenterology, 2022, v. 13, n. 6, p. e00500, doi. 10.14309/ctg.0000000000000500
- By:
- Publication type:
- Article